02566.HK
Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd.
HKSE · Healthcare · Biotechnology · CN
HKD 5.25
−0.66%Price chart
Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
—
Market Cap
HKD 1.27B
MomentumView details →
1D Return
−0.66%
YTD Return
−30.56%
RSI (14)
45.5
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
—
Market Cap
HKD 1.27B
RSI (14)
45.5
MomentumView details →
1D Return
−0.66%
YTD Return
−30.56%
Similar companies
Latest newsMore news →
Jiyuan Gene announced that its board resolved to continue its H-share buyback plan, repurchasing up to 100 million RMB of H-shares on the open market with its own funds before the buyback mandate expires.16d agoJiuyuan Gene announced its interim results for the six months ended June 2026, with revenue of RMB 631 million, down 1.2% year-on-year, and net profit of RMB 91.269 million, up 1.2% year-on-year.16d ago